Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril

Phytomedicine

Volumn 17, Issue 13, 2010, Pages 1016-1026

  Asdaq, S M ^a   Inamdar, M N ^b  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

^b AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

ACE inhibition; Captopril; Garlic; Interaction; Isobolographic analysis; S allyl cysteine sulphoxide; Synergy effect

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CATALASE; CHOLESTEROL; CREATINE KINASE MB; CYSTEINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRUCTOSE; GARLIC EXTRACT; GLUCOSE; ISOPRENALINE; LACTATE DEHYDROGENASE; S ALLYL CYSTEINE SULPHOXIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; EVALUATION; FEMALE; FLUID INTAKE; GARLIC; GLUCOSE BLOOD LEVEL; GUINEA PIG; HEART; HEART PROTECTION; HISTOLOGY; HOMOGENATE; HYPERTENSION; ILEUM; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; CREATINE KINASE; CYSTEINE; DRINKING; DRUG SYNERGISM; FEMALE; GARLIC; GUINEA PIGS; HEART; HYPERTENSION; ILEUM; ISOPROTERENOL; LIPIDS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR;

ALLIUM SATIVUM; ANIMALIA; CAVIA; RATTUS;

EID: 77957803842     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.07.012     Document Type: Article

References (58)

1. Agarwal K.C. Therapeutic action of garlic constituents. Med. Res. Rev. 1996, 16:11-124.
2. Ali M., Thomson M. Consumption of garlic, clove a day could be beneficial in preventing thrombosis. Prostaglandin Leukot. Essent. Fatty Acids 1995, 53:221-224.
3. Al-Qattan K.K., Alnaqeeb M.A., Ali M. The antihypertensive effect of garlic (Allium sativum L.) in the rat two-kidney-one-clip Goldblatt model. J. Ethnopharmacol. 1999, 66:217-222.
4. Aqel M.B., Gharaibah M.N., Salhab A.S. Direct relaxant effects of garlic juice on smooth and cardiac muscles. J. Ethnopharmacol. 1991, 33:13-19.
5. Asdaq S.M., Inamdar M.N. Pharmacodynamic interaction of garlic with captopril in ischemia-reperfusion induced myocardial damage in rats. Pharmacologyonline 2008, 2:875-888.
6. Asdaq S.M., Inamdar M.N. The potential for interaction of hydrochlorothiazide with garlic in rats. Chem. Biol. Interact. 2009, 181:472-479.
7. Asdaq S.M., Inamdar M.N. Pharmacodynamic interaction of garlic with hydrochlorothiazide in rats. Indian J. Physiol. Pharmacol. 2009, 53:127-136.
8. Asdaq S.M., Inamdar M.N. Pharmacodynamic interaction of captopril with garlic in isoproterenol induced myocardial damage in rat. Phytother. Res. 2010, 24:720-725.
9. Asdaq S.M., Inamdar M.N., Asad M., Nanjundan P.K. Interaction of propranolol with garlic in isoproterenol induced myocardial infarction in rat. J. Pharmacol. Toxicol. 2008, 3:414-424.
10. Banerjee A. Effect of aqueous extract of garlic on arterial blood pressure of normotensive and hypertensive rats. Artery 1979, 2:369-373.
11. Banerjee K.S., Moulik S.K. Effect of garlic on cardiovascular disorders: a review. Nutr. J. 2002, 1:1-14.
12. Banerjee S.K., Dinda A.K., Manchanda S.C., Maulik S.K. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic-reperfusion injury. BMC Pharmacol. 2002, 2:16-21.
13. Block E. The chemistry of garlic and onion. Sci. Am. 1985, 252:114-119.
14. Bordia A. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978, 29:355-360.
15. Bordia A., Joshi H.K., Sandhya Y.K., Bhu N. Effects of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery diseases. Atherosclerosis 1978, 28:155-159.
16. Bordia A., Verma S.K., Vyas A.K., Bedi H.K. Effect of essential oil of onion and garlic on experimental atherosclerosis in rabbits. Atherosclerosis 1977, 26:379-386.
17. Buerke I., Prufer D., Dahm M., Oelert H., Meyer J., Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J. Pharmacol. Exp. Ther. 1998, 286:429-438.
18. Chu Q., Lee D.T., Tsao S.W., Wang X., Wong Y.C. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU Int. 2007, 99:925-932.
19. Chutani S.K., Bordia A. The effect of fried versus raw garlic on fibrinolytic activity in man. Atherosclerosis 1981, 38:417-421.
20. Dai S., McNeill J.H. Fructose-induced hypertension in rats is concentration- and duration-dependent. J. Pharmacol. Toxicol. Methods 1995, 33:101-107.
21. Das D.K., Maulik N., Moraru I.I. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia/reperfusion, hyperthermia and oxidative stress. J. Mol. Cell. Cardiol. 1995, 27:181-193.
22. Dimo T., Azay J., Tan P.V., Pellecuer J., Cros G., Bopelet M., Serrano J.J. Effects of the aqueous and methylene chloride extracts of bidenspilosa leaf on fructose-hypertensive rats. J. Ethnopharmacol. 2001, 76:215-221.
23. Erich F., Elastner M. Inhibition of nitrite formation from hydroxyl ammonium chloride. A simple assay of super oxide dismutase. Anal. Chem. 1976, 70:616-620.
24. Eva M.L. Mechanism of pH dependent hydrogen peroxide cytotoxicity in-vitro. Arch. Biochem. Biophys. 1988, 365:362-372.
25. Faulx M.D., Ernsberger P., Vatner D., Hoffman R.D., Lewis W., Strachan R. Strain-dependent β-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H30-H36.
26. Fossati P., Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 1982, 28:2077-2082.
27. Foushee D.B., Ruffin J., Banerjee U. Garlic as a natural agent for the treatment of hypertension: a preliminary report. Cytobios 1982, 34:145-152.
28. Freeman F., Kodera Y. Garlic chemistry: stability of S-(2-propenyl) 2-propene-1-sulfinothioate (allicin) in blood, solvents and simulated physiological fluids. J Agric. Food Chem. 1995, 43:2332-2338.
29. Hayes M., Rushman T., Goldberg M. Inhibition of hepatocarcinogenic responses to 1,2-dimethylhidrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis 1987, 8:1155-1157.
30. Herrera-Mundo M.N., Silva-Adaya D., Maldonado P.D., Galvan-Arzate S., Andres-Martinez L., Perez-De La Cruz V., Pedraza-Chaverri J., Santamaria A. S-allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction. Neurosci. Res. 2006, 56:39-44.
31. Hsu C.C., Lin C.C., Liao T.S., Yin M.C. Protective effect of s-allylcysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 2006, 44:393-397.
32. Hwang I.S., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10:512-516.
33. Itokawa Y., Inone K., Sasagawa S., Fugiwara M. Effect of S-methylcysteine sulfoxide, s-allylcysteine sulfoxide and related sulfur-containing amino acids on lipid metabolism of experimental hypercholesterolemic rats. J. Nutr. 1973, 103:88-93.
34. Jurgens H., Haass W., Castaneda T.R., Schurmann A., Koebnick C., Dombrowski F., Otto B., Nawrocki A.R., Scherer P.E., Spranger J., Ristow M., Joost H., Havel P.J., Tschop M.H. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes. Res. 2005, 13:1146-1156.
35. Karthikeyan K., SaralaBai B.R., Devaraj N. Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats. Int. J. Cardiol. 2007, 115:326-333.
36. Kim J.M., Chang N., Kim W.K., Chun H.S. Dietary S-allyl-l-cysteine reduces mortality with decreased incidence of stroke and behavioral changes in strokeprone spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 2006, 70:1969-1971.
37. Kim J.M., Lee J.C., Chang N., Chun H.S., Kim W.K. S-allyl-l-cysteine attenuates cerebral ischemic injury by scavenging peroxynitrite and inhibiting the activity of extracellular signal-regulated kinase. Free Radic. Res. 2006, 40:827-835.
38. Kosmala M., Oledzka K., Lewandowski K., Filczewski M., Miłobedzka J. A comparison of antihypertensive properties of captopril and enalapril after single and multiple oral administration in spontaneously hypertensive rats. Pol. J. Pharmacol. Pharm. 1992, 44:437-442.
39. Lawson L.D. Garlic: a review of its medicinal effects and indicated active compounds. Phytomedicines of Europe: chemistry and biological activity. ACS Symposium Series, 691 1988, 176-209. American Chemical Society. L.S. Lawson, R. Bauer (Eds.).
40. Makheia A.N., Vanderhock J.Y., Bailey J.M. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. Lancet 1979, 1:781-785.
41. Mc Gown M.W., Artiss J.D., Strandberg D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983, 29:538-542.
42. Nakagawa S., Kasuga S., Matsura H. Prevention of liver damage by aged garlic extract and its components in mice. Phytother. Res. 1989, 3:50-53.
43. Numagami Y., Ohnishi S.T. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J. Nutr. 2001, 131:1100-1105.
44. Oron-Herman M., Rosenthal T., Mirelman D., Miron T., Rabinkov A.D., Wilchek M., Sela B. The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome. Atherosclerosis 2005, 183:238-243.
45. Padmanabhan M., Prince P.S. Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study. Toxicology 2006, 224:128-137.
46. Rahman K. Garlic and aging: new insights into an old remedy. Ageing Res. Rev. 2003, 2:39-56.
47. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
48. Reddy S.S., Karuna R., Baskar R., Saralakumari D. Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose-fed rats. Horm. Metab. Res. 2008, 40:44-49.
49. Reiser S. Effects of dietary sugars in metabolic risk factors associated with heart disease. Nutr. Health 1985, 3:203-216.
50. Rubin B., Laffan R.J., Kotler D.G., O"Keefe E.H., Demaio D.A., Goldberg M.E. SQ 14,225 (d-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme. J. Pharmacol. Exp. Ther. 1978, 204:271-280.
51. Samson R.R. Effects of dietary garlic on temporal drift on platelet aggregation. Atherosclerosis 1982, 44:119-120.
52. Tallarida R. Statistical analysis of drug combinations for synergism. Pain 1992, 49:93-97.
53. Tallarida R. Drug Synergism and Dose-Effect Data Analysis 2000, Chapman & Hall/CRC, Boca Raton.
54. Tallarida R., Porreca F., Cowan A. A statistical analysis of drug-drug and site-site interaction with isobolograms. Life Sci. 1989, 45:947-961.
55. Thorburn A.W., Storlein L.H., Jemkins A.B., Khouri S., Kraegen E.W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr. 1989, 49:1155-1163.
56. Wagner H., Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16:97-110.
57. Welch C., Wuarin L., Sidell N. Antiproliferative effect of the garlic compound S-allylcysteine on human neuroblastoma cell in vitro. Cancer Lett. 1992, 63:A211-219.
58. Zheziang Institute of Traditional Chinese Medicine The effect of essential oil of garlic on hyperlipidemia and platelet aggregation. J. Tradit. Chin. Med.. 1986, 6:117-120.